Emerging research suggest Retatrutide , a dual activator targeting both GLP-1 and another hormone, may provide a notable step forward for weight treatment. Initial patient trials have demonstrated considerable reductions in visceral fat , potentially surpassing existing body composition treatments. Despite this, more study is needed to completely a